INTRODUCTION
Chronic cerebral hypoperfusion (CCH) is one of the critical risk factors for vascular dementia, and it may also play a role in cognitive decline in Alzheimer's disease (AD) [1] . Hypoperfusion is also implicated in other neurodegenerative diseases, such as multiple sclerosis [2] and Parkinson's disease [3] . A common feature of such neurodegenerative diseases is the accumulation and deposition of misfolded or unfolded proteins [4] [5] [6] . Not surprisingly, a rat model of CCH elicited by bilateral common carotid artery ligation (BCCAL) and two-vessel occlusion (2VO) stimulates the processing of aberrant amyloid precursor protein (APP). This includes the production of β-amyloid, which was more pronounced in the cortex than in the hippocampus [7] . Given the phenotypic similarities between neurodegenerative disorders and CCH, we suspected that altered protein processing, such as the macroautophagy (hereafter referred to as autophagy) and endoplasmic reticulum stress (ERS), which are already implicated in AD [8, 9] , may participate in vascular cognitive impairment induced by CCH. Autophagy is a fundamental, evolutionarily conserved process that degrades and recycles cellular constituents. It provides a select pathway to maintain cellular homeostasis by clearing damaged organelles and abnormally aggregated proteins. Disturbances of autophagy have been implicated in various diseases, including neurodegenerative disorders, stroke, heart diseases and cancer [10] [11] [12] [13] . Under most pathological conditions, it is believed that a moderate level of autophagy plays a protective role. However, defective or excessive autophagy may lead to cell death [14] . For example, in a mouse model of AD, reduced expression of beclin1 may be partially responsible for amyloid-β accumulation [15] . As a consequence of prolonged and intensive cell stress, the autophagy mechanism may become overloaded due to the increase in damaged or dysfunctional macromolecules and organelles. In this case, autophagy may promote cell death instead, though it is still unclear whether autophagy is a deliberate mechanism of programmed cell death or one of the consequences of its severity and/or extended duration [16] . ERS or the unfolded protein response (UPR) in neurons was reported to activate or be activated by autophagy under certain conditions [17] [18] [19] . Under acute cellular stress, the UPR is activated to protect cells against the toxic build-up of nascent, misfolded or unfolded proteins. Glucose-regulated protein 78 (GRP78), a member of the heat shock protein 70 family, is the most important ER chaperone. It activates three ERS pathways to help cells manage stress [20] .
However, when ERS is sustained or overwhelming and the function of the ER is not restored, the afflicted cells may be removed by apoptosis [21] . In this case, the apoptosis-related factors C/EBP homologous protein (CHOP) and caspase-12 are upregulated or activated [22] . It remains unknown whether ERS and autophagy are implicated in CCH. Because cell stress leading to protein aggregation and potential cell death are involved in many neuropathologies, therapeutic strategies could aim at reducing the activation of those cellular responses or pathways. Lipoxin A 4 methyl ester (LXA 4 ME) is a type of lipoxin analog that is relatively stable and more potent than endogenous lipoxins. The neuroprotective effects of LXA 4 ME have been gradually recognized. It was reported that LXA 4 ME significantly reduced cerebral ischemia/reperfusion injury by ameliorating blood-brain barrier dysfunction, regulating inflammation-related signaling pathways and decreasing the production of pro-inflammatory cytokines [23] [24] [25] . In our previous study, we demonstrated the protective effect of LXA 4 ME on cognitive impairments in 2VO rats by activating the extracellular signal regulated kinase/nuclear factor erythroid 2-related factor 2 (ERK/Nrf2) signaling pathway [26] . In the experiments described here, we tested the idea that LXA 4 ME might alleviate cognitive deficits by targeting some autophagy-and ERrelated factors in 2VO rats.
MATERIALS AND METHODS

Rats
The Laboratory Animal Centre of Hebei Medical University provided male Sprague-Dawley (SD) rats (250-300 g body weight). The experimental procedures were performed in accordance with the regulations for laboratory animal management from the Ministry of Science and Technology of the People's Republic of China [1988] no. 134. All efforts were made to alleviate animal suffering and minimize the number of animals used. As such, the results of the Morris water maze test performed in our previous study were used here [26] . The details of the 2VO surgery and the microinjection procedures of LXA 4 ME were published previously [26] . We used the same paraffin-embedded rat brains and frozen hippocampus tissue, which were stored at -80ºC until needed. LXA 4 ME was purchased from Cayman Chemical Company. As described previously, the rats were randomly assigned to one of four groups: (1) sham + saline; (2) 2VO + saline; (3) 2VO + LXA 4 ME (10 ng/day); (4) 2VO + LXA 4 ME (100 ng/day). Brain sections (5-µm thick) containing the hippocampus were routinely processed with hematoxylin & eosin (H & E) staining.
RT-PCR
RT-PCR was conducted to detect X-box binding protein 1 (XBP-1) mRNA splicing. Total RNA was isolated from hippocampus tissue using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Electrophoresis on a 2% agarose gel was run to check for RNA degradation. A Nanodrop 2000/2000c spectrophotometer (Thermo-Fisher Scientific) was used to estimate the concentration and purity of the RNA. Reverse transcription of RNA was carried out according to the protocol of the EasyScript First-Strand cDNA Synthesis SuperMix Kit (Transgen). The primers were synthesized by Sangon Biotechnology Co. Ltd. XBP-1 was amplified via PCR using primers spanning the splice junction. The primer sequences are: for GAPDH, forward 5'-TGAACGGGAAGCTCACTGG-3' and reverse 5'-GCTTCACCACCTTCTT GATGTC-3'; XBP-1, forward 5'-AGCGCTTGGGGATGGATG-3' and reverse 5'-CCATGGGGAGATGTTCTGGA-3'. The PCR program was set according to the manufacturer's guidelines: 94ºC for 3 min, 35 cycles of 94ºC for 20 s and 60ºC for 1 min, and 72ºC for 5 min. Finally, the amplification products were detected via 3% (w/v) agarose gel electrophoresis with 0.01% (v/v) Goldview staining.
Western blotting
Frozen hippocampal tissue was homogenized in ice-cold Radio Immuno Precipitation Assay (RIPA) buffer following the manufacturer's protocols (Solarbio) and incubated on ice for 30 min. Tissue was centrifuged at 12,000 g at 4ºC for 10 min and the precipitate was discarded. Protein concentration was determined using the BCA method (Pierce). The protein samples were electrophoresed through sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE) and transferred to PVDF membranes (Millipore Corporation). Membranes were blocked with 5% non-fat milk in Tris-buffered saline Tween-20 (TBST) for 2 h at room temperature, then incubated with primary antibodies against the following proteins at 4ºC overnight with gentle shaking: GRP78 (1:1,000, Signalway Antibody), CHOP (1:1,000, Cell Signaling Technology Inc.), beclin1 (1:200, Abgent), LC3 (1:200, Abgent), total-mTOR (t-mTOR; 1:2,000, Signalway Antibody) and phospho-mTOR (p-mTOR; Ser2448; 1:1,000, Anbo Biotechnology Co., Ltd.). Membranes were then incubated with the relevant secondary antibodies (peroxidase-conjugated affinipure goat anti-rabbit or goat anti-mouse IgG (H+L), 1:10,000, Proteintech Group Inc.) for 2 h at room temperature. Proteins were detected using the ECL method and β-actin served as a loading control protein. The bands were scanned and ImageJ software (version 1.30v; Wayne Rasband, National Institutes of Health) was used to analyze the relative density of each band.
Statistical analysis
Data are expressed as means ± SEM. Statistical analysis was performed with one-way analysis of variance (ANOVA) for all the data. Intergroup comparisons were analyzed using Student-Newman-Keuls (SNK) tests. p < 0.05 was considered statistically significant.
RESULTS
LXA 4 ME treatment attenuates CCH-induced morphological changes in the hippocampus Using H & E staining, we found that 2VO rats exhibited the typical pathological changes of pyramidal cell layer morphology in the CA1 and CA3 regions of the hippocampus, including loose and irregular arrangements of pyramidal cells, neuronal swelling and shrunken neurons with darkly stained and condensed nuclei. However, administering 100 ng/day of LXA 4 ME partly alleviated the hippocampal damage caused by CCH (Fig. 1) . 
LXA 4 ME downregulated the level of beclin1, inhibited the conversion of LC3-I to LC3-II and upregulated p-mTOR (Ser2448) and t-mTOR in 2VO rats
To examine the level of autophagy in 2VO rats, we studied the expression levels of beclin1 and microtubule-associated protein 1 light chain 3 (LC3), two key markers of autophagy [27] . We found significant differences in the beclin1 content and the ratio of LC3-II to LC3-I between the groups (F (3, 20) = 3.763, p < 0.05; F (3, 20) = 9.939, p < 0.01, respectively). There was a significant increase in beclin1 expression (p < 0.01) and LC3-II (p < 0.01) in the 2VO group compared with the sham + saline group. Whether autophagy is beneficial or harmful to cell survival is debated and it varies among different cerebral ischemic conditions [28] . We found that it may correlate with CCH injury and cognitive impairments in 2VO rats. Importantly, administration of LXA 4 ME reduced the level of beclin1 and the ratio of LC3-II to LC3-I (Fig. 2) . Fig. 2 . LXA 4 ME upregulated p-mTOR, downregulated the level of beclin1 and inhibited conversion of LC3-I to LC3-II in 2VO rats. It also upregulated GRP78, downregulated CHOP, and promoted the expression of sXBP-1 and uXBP-1 mRNA. A and E -Representative Western blots of p-mTOR, mTOR, beclin1, LC3, GRP78 and CHOP. β-actin served as the control for protein loading. F -RT-PCR of the XBP-1 mRNA. GAPDH served as the internal control gene. B, C, D, G and H -Quantitative analysis of the data from western blots (n = 6) or RT-PCR (n = 6). The results were normalized to the sham + saline group (means ± SEM). *p < 0.05, **p < 0.01 vs. sham + saline group; # p < 0.05, ## p < 0.01 vs. 2VO + saline group.
As a crucial metabolic sensor, the mammalian target of rapamycin (mTOR) plays critical roles in regulating many pathophysiological processes. Because activation of mTOR and its substrates may suppress autophagy [29, 30] , we measured the p-mTOR (Ser2448) and t-mTOR protein levels. While we found significant differences in the expression of p-mTOR (Ser2448; F (3, 20) = 6.473, p < 0.01), the variation in expression of t-mTOR was not statistically significant (F (3, 20) = 2.073, p > 0.05). Compared with the control rats, p-mTOR (Ser2448) and t-mTOR were both downregulated in the 2VO group (p < 0.01 and p > 0.05, respectively). Conversely, 2VO rats treated with LXA 4 ME (10 ng/day and 100 ng/day) demonstrated p-mTOR (Ser2448; p < 0.05, p < 0.01) and t-mTOR (p > 0.05, p > 0.05) upregulation (Fig. 2) .
LXA 4 ME upregulated GRP78, downregulated CHOP and promoted the splicing of XBP-1 mRNA in 2VO rats
To determine whether ERS-related mechanisms take part in cognitive deficits caused by CCH, we investigated two key regulators of ERS, GRP78 and CHOP via western blot analysis. Statistical analysis showed significant differences between the groups for both GRP78 and CHOP (F (3, 20) = 6.719, p < 0.01; F (3, 20) = 10.994, p < 0.05, respectively). However, GRP78 protein expression between the sham + saline group and the 2VO + saline group was not significantly different (p > 0.05), while CHOP was significantly upregulated by CCH (p < 0.01). Compared with the 2VO group, the administration of LXA 4 ME (100 ng/day) dramatically increased GRP78 (p < 0.01) while downregulating CHOP expression (p < 0.01). A low dose of LXA 4 ME (10 ng/day) also changed the expression of the two proteins slightly with no statistical significance. XBP-1 is an important transcription factor in the process of ERS. It regulates the expression of many key molecules, including GRP78, and it has an unspliced and a spliced form. Spliced XBP-1 (sXBP-1) is translated into larger, active transcription factor XBP-1, while unspliced XBP-1 (uXBP-1) is translated into smaller, inactive XBP-1 [31] . XBP-1 mRNA was assayed using RT-PCR. sXBP-1 and uXBP-1 expression was significantly different between the groups (F (3, 20) = 9.484, p < 0.01; F (3, 20) = 8.694, p < 0.01, respectively). The expression of sXBP-1 mRNA did not change in the 2VO group compared with the control group (p > 0.05). uXBP-1 mRNA expression was upregulated in the 2VO group (p < 0.01). We found the administration of LXA 4 ME (100 ng/day) induced the splicing of XBP-1 mRNA significantly (p < 0.01). An increased level of uXBP-1 in the LXA 4 ME (100 ng/day) treatment group was also observed (p < 0.01) compared with the 2VO group (Fig. 2) .
DISCUSSION
While many neurodegenerative diseases share dysfunctional protein-processing mechanisms, it is unknown whether autophagy-and ERS-related mechanisms play a role in CCH-induced cognitive impairments. To uncover if these mechanisms are involved, we used a rat model of CCH and examined markers of autophagy and ERS. Moreover, while we previously showed that LXA 4 ME treatment is protective in 2VO rats via the ERK/Nrf2 pathway, we found that LXA 4 ME also reduced ERS and autophagy. To our knowledge, this is the first report that links LXA 4 ME-induced cerebral protection and the regulation of autophagy and ERS mechanisms in a CCH rat model. mTOR, a ubiquitous protein kinase, is not only involved in metabolic processes, but also participates in autophagy regulation [32] . mTOR is a Ser/Thr kinase that forms two different protein complexes, mTORC1 and mTORC2 [33, 34] . The former is thought to negatively regulate autophagy and under certain stressful circumstances, such as low energy production, mTORC1 is inhibited, which could be one of the factors to promote autophagy [35] . mTORC1 is primarily phosphorylated on Ser2448, whereas mTORC2 is primarily phosphorylated on Ser2481 [36, 37] . We found that CCH reduced the p-mTOR (Ser2448) and t-mTOR, promoting autophagy through greater expression of beclin1 and LC3-II. Thus, in CCH, mTORC1 is likely the relevant mTORC isoform. One interesting finding of our study is that the expression of t-mTOR in the hippocampus decreased at day 20 following 2VO surgery [26] , albeit with no statistical significance, suggesting that CCH not only regulates the phosphorylation of mTOR, but also affects the gene expression of mTOR at the level of transcription or translation. Nevertheless, LXA 4 ME prevented the downregulation of mTOR expression and mTOR phosphorylation in 2VO rats. The results suggest that mTOR may serve as a therapy target in CCH injury. As autophagy is viewed as a double-edged sword in many diseases [38, 39] , we hesitate to state whether enhanced autophagy is a harmful or beneficial reaction, though LXA 4 ME, which is protective, downregulated autophagy-related proteins in 2VO rats. We propose two explanations for our results. First, during CCH, increased autophagy may contribute to neuronal death, similar to autophagic cell death, which was described previously [40] , or type II programmed cell death [41] . In addition, LXA 4 ME rescued a population of dying neurons via unselected autophagy inhibition. Shen and Codogno recently questioned the traditional definition of autophagic cell death. They propose that autophagic cell death should be based on causality instead of on morphology [42] . Our research failed to demonstrate any in vivo evidence of autophagic cell death according to their new definition. An alternate explanation is that autophagy was activated to cope with chronic stress, although it might be an unsuccessful effort [43] . Generally, autophagy is viewed as a self-defense reaction that provides energy and nutrients for the cells suffering from stress [44] . Unlike an acute ischemia model, 2VO rats receive about 70% of the original cerebral blood flow rate after the surgery [45] . The oxygen, nutrient and energy levels are thus relatively insufficient for neurons, and autophagy may be a last resort. Following LXA 4 ME administration, autophagy was suppressed to some extent, but whether the reduction of autophagy was the cause or consequence of tissue protection remains unclear.
ER-resident chaperones, such as GRP78, take part in the UPR to cope with cell stress. By activating three sensors in the ER membrane, GRP78 regulates transcription and translation to alleviate ERS [46] . Generally, overexpressed GRP78 and CHOP and the activation of the inositol-requiring enzyme-1 (IRE1)/XBP-1 pathway are considered some of the markers of UPR. IRE1 produces a spliced isoform of XBP-1 mRNA, enhancing the expression of ER chaperones. Unexpectedly, the levels of GRP78 and XBP-1 mRNA splicing in the 2VO model were very similar to those for the control rats. We cannot discount the possibility that these two factors operate early in hypoperfusion, which had occurred before we examined brain structure and protein levels. ER chaperones normally render neurons more resistant to ER damage, and we suggest that they are relatively insufficient or limited under chronic stress. In this study, LXA 4 ME (100 ng/day) dramatically promoted the expression of GRP78 and sXBP-1 mRNA, protecting neurons from the CHOP-related cell death pathway. Katayama et al. reported that GRP78 protected against neuronal death caused by ERS [47] . Our current study suggests that LXA 4 ME regulates ERrelated factors to protect the brain during chronic stress, like CCH. XBP-1-deficient mice were reported to have an increased level of autophagy, which correlates with a stronger resistance to neurodegenerative diseases [48] . However, after LXA 4 ME administration, we found elevated levels of sXBP-1 mRNA, which is translated into the active form of XBP-1, and reduced autophagy. Autophagy and ERS mechanisms may play various roles in different disease conditions. In addition, our study has certain limitations, including the fact that only male rats were examined, and that we studied only one time point after 2VO surgery (i.e., 14 days before the Morris water maze tests [26] ). Moreover, we did not test any mTOR inhibitors. Therefore, future studies should study how mTOR inhibitors affect autophagy and ERS in 2VO rats. Our results further demonstrate that LXA 4 ME exerts protective effects against CCH injury through downregulation of autophagy and regulation of the expression of some important factors in ERS. These results suggest that LXA 4 ME may be a promising therapeutic drug for the treatment of cognitive impairment following CCH.
